Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Shuo Dun"'
Autor:
Qiu-Hong Wang, Yang-Yang Wang, Jing Wang, Li-Ying Liu, Jing Gao, Guo-Zhen Hao, Chen Chen, Qian Lu, Shuo Dun, Qi Zhang, Li-Ping Zou
Publikováno v:
Italian Journal of Pediatrics, Vol 50, Iss 1, Pp 1-7 (2024)
Abstract Background Addison’s disease and X-linked adrenoleukodystrophy (X-ALD) (Addison’s-only) are two diseases that need to be identified. Addison’s disease is easy to diagnose clinically when only skin and mucosal pigmentation symptoms are
Externí odkaz:
https://doaj.org/article/b27a6c2b25a246bd80116b2cf1696990
Autor:
Lin Wan, Wen He, Yang-Yang Wang, Yong Xu, Qian Lu, Meng-Na Zhang, Qiu-Hong Wang, Shuo Dun, Li-Ying Liu, Xiu-Yu Shi, Jing Wang, Lin-Yan Hu, Bo Zhang, Guang Yang, Li-Ping Zou
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 15 (2022)
Background: Vigabatrin (VGB) is currently the most widely prescribed first-line medication for individuals with infantile spasms (IS) and especially for those with tuberous sclerosis complex (TSC), with demonstrated efficacy. Meanwhile, its adverse e
Externí odkaz:
https://doaj.org/article/0fb0ac9f47e74d1fa23c9e59eacc5c00
Autor:
Su, Xin1 (AUTHOR) suxin900220@163.com, Shuo, Dun1 (AUTHOR), Luo, Yanqiu1 (AUTHOR), Pan, Xue1 (AUTHOR), Yan, Dawei1 (AUTHOR), Li, Xuesong1 (AUTHOR), Lin, Weishan1 (AUTHOR), Huang, Dongming1 (AUTHOR), Yang, Jianmei1 (AUTHOR), Yuan, Chunxiu1 (AUTHOR), Liu, Qinfang1 (AUTHOR), Teng, Qiaoyang1 (AUTHOR) tengqy@shvri.ac.cn, Li, Zejun1 (AUTHOR) tengqy@shvri.ac.cn
Publikováno v:
Viruses (1999-4915). May2022, Vol. 14 Issue 5, p932-932. 17p.
Publikováno v:
Seizure. 99
To assess the safety of inactivated coronavirus 2019 disease (COVID-19) vaccine in tuberous sclerosis complex (TSC) patients with epilepsy.All patients with epilepsy were selected from Efficacy and Safety of Sirolimus in Pediatric Patients with Tuber
Autor:
Yan-Wen Shen, Yang-Yang Wang, Meng-Na Zhang, Yong Xu, Qian Lu, Wen He, Hui-Min Chen, Li-Ying Liu, Ling-Yu Pang, Qiu-Hong Wang, Shuo Dun, Yu-Fen Li, Jing Gao, Fang Han, Li-Ping Zou
Publikováno v:
Seizure. 97
To evaluate whether sirolimus treatment could relieve the later burden of new-onset seizures in patients with tuberous sclerosis complex (TSC) prior to epilepsy.A real-world matched case-control study was nested in another registry cohort study. Infa
Autor:
Ling-Yu Pang, Yang Gao, Yang-Yang Wang, Shuo Dun, Wen He, Kai-Feng Xu, Yu-Fen Li, Wenshuai Xu, Huimin Chen, Meng-Na Zhang, Xiao-Mei Luo, Qiu-Hong Wang, Li-Ying Liu, Xiao-Yan Yang, Shu-Fang Ma, Lu-Lu Huang, Xiao-Qiao Chen, Xinlun Tian, Li-Ping Zou
Publikováno v:
SSRN Electronic Journal.
Background: Previously known as the anti-rejection drug, then famous for its efficacy on many mTOR-regulated diseases, sirolimus is now reported as the drug to reverse the process of many age-related diseases, rejuvenate immunity, and extend life spa
Publikováno v:
The journal of physical chemistry. B. 114(8)
A novel type of hollow polymeric particles was prepared according to a strategy consisting of three major steps: the synthesis of template particles (PMV) based on maleic anhydride/vinyl acetate; the formation of core/shell particles by using maleic
Autor:
Shuo-dun, Xie
Publikováno v:
Zhonghua yi xue za zhi. 85(34)
Autor:
Xie SD
Publikováno v:
Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2005 Sep 07; Vol. 85 (34), pp. 2380-1.